The Rising Incidence of Tuberculosis

Citron K.M. , Girling D.J. Tuberculosis. In: Weatherall DJ , Ledingham JGG , and Warrell DA , eds. Oxford Textbook of Medicine. 1987: 5.278–5.299

Hcym B. , Honoré N. , Truffot–Pernot C. Implications of multidrug resistance for the future of short–course chemotherapy of tuberculosis. Lancet 1994; 344: 293–8.

Medical Research Council. Cardiothoracic Epidemiology Group. National survey of notifications of tuberculosis in England and Wales in 1988. Thorax 1992; 47: 770–5.

Lung and Asthma Information Agency, London: Respiratory Tuberculosis Fact Sheet 92/5. Department of Health Sciences, St George's Hospital

Jereb J.A. , Kelly G.D. , Dooley S.W. , Cauthen G.M. , Snider D.E. Tuberculosis mortality in the United States: Final Data 1990. MMWR CDC Surveill Summ 1992; 40: (SS3)

CDC. Tuberculosis morbidity—United States, 1992. Morb Mortal Wkly Rep 1993; 42(36): 696–704.

Brudney K. , Dobkin J. Resurgent tuberculosis in New York City. Am Rev Resp Dis 1991; 144: 745–9.

Frieden T.R. , Sterling T. , Pablos-Mendez A. , Kilburn J.O. , Cauthen G.M. , Dooley S.W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521–6.

Neville K. , Bromberg A. , Bromberg R. , Bonk S. , Hanna B.A. , Rom W.N. The third epidemic—multidrug-resistant tuberculosis. Chest 1994; 105: 45–8.

Goble M. , Iseman M.D. , Madsen L.A. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med 1993; 328: 527–32.

Edlin B.R. , Tokars J.I. , Grieco MM An outbreak of multidrug resistant tuberculosis among hospitalised patients with the acquired immune deficiency syndrome. N Engl J Med 1992; 326: 1514–21.

Fischl M.A. , Uttamchandani R.B. , Daikos G.L. An outbreak of tuberculosis caused by multiple drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177–83.

CDC. Tuberculous Morbidity—United States, 1994. Morb Mortal Wkly Rep 1995; 44(20): 387–94.

Weis S.E. , Slocum P.C. , Frances X. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179–84.

Hayward A.C. , Watson J.M. Tuberculosis in England and Wales 1982–1993: notifications exceed predictions. Commun Dis Rep CDR Rev 1995; 5: R29–33

Sheldon C.N. , King K. , Cock H. , Wilkinson P. , Barnes N.C. Notification of tuberculosis: how many cases are never reported? Thorax 1992; 47: 1015–18.

Brown J.S. , Wells F. , Duckworth G. , Paul E.A. , Barnes N.C. Improving notification rates for tuberculosis. BMJ 1995; 310: 974

Roderick P.J. , Connelly J.B. The problems of monitoring tuberculosis in an inner-city health district: Integrated Information is Required. Pub Hlth 1992; 106: 193–201.

Darbyshire J.H. Tuberculosis: old reasons for a new increase? BMJ 1995; 310: 954–5.

Outbreak of hospital acquired multidrug resistant tuberculosis. CDR Wkly 1995; 5(34):

Warburton A.R.E. , Jenkins P.A. , Waight P.A. , Watson J.M. Drug resistance in isolates of mycobacterium tuberculosis in England and Wales 1982–1991. CDR Rev 1993; 3: 175–9.

Raviglione M.C. , Snider D.E. , Kochi A. Global epidemiology of tuberculosis. JAMA 1995; 273: 220–6.

Burns D.N. , Gelbert G.A. , Crone R.K. Tuberculosis in Eastern Europe and the former Soviet Union: how concerned should we be? Lancet 1994; 343: 1445–6.

Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1–6.

Bloom B.R. , Murray C.J.L. Tuberculosis: commentary on a resurgent killer. Science 1992; 257: 1055–64.

Kochi A. , Vareldzis B. , Styblo K. Multidrug resistant tuberculosis and its control. Res Microbiol 1993; 144: 104–10.

Murray C.J.L. , Styblo K. , Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Tuberc Lung Dis 1990; 65: 6–24.

Weekly Epidemiological Record 1995 (No. 2)

Nunn P. , Kibuga D. , Elliott A. , Gathua S. Trans R Soc Trop Med Hyg 1990; 84(suppl 1): 9–13

Schulzer M. , Fitzgerald J.M. , Enarson S. , Grzybowski S. An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. Tuberc Lung Dis 1992; 73: 52–8.

Watson J.M. , Meredith S.K. , Whitemore-Overton E. , Bannister B. , Darbyshire J.H. Tuberculosis and HIV: estimates of the overlap in England and Wales. Thorax 1993; 48: 199–203.

Spence D.P.S. , Hotchkiss J. , Williams C.S.D. , Davies P.D.P. Tuberculosis and poverty. BMJ 1993; 307: 759–61.

Bhatti N. , Law M.R. , Morris J.K. , Halliday R. , Moore-Gillon J. Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ 1995; 310: 967–9.

Drucker E. , Alcabes P. , Bosworth W. , Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet 1994; 343: 1482–5.

Goldman J.M. , Teale C. , Cundall D.B. , Pearson S.B. Childhood tuberculosis in Leeds 1982–90: social and ethnic factors and the role of the contact clinic in diagnosis. Thorax 1994; 49: 184–5.

Citron K.M. , Southern A. , Dixon M. Out of the Shadow. London: Crisis, 1995

Drobniewski F. Tuberculosis in prisons—forgotten plague. Lancet 1995; 346: 948–9.

Murray C.J. , DeJonghe E. , Chum H.J. , Nyangulu D.S. , Salomao A. , Styblo K. Cost effectiveness of chemotherapy of pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338: 1305–8.

Mahmoudi A. , Iseman M.D. Pitfalls in the care of patients with tuberculosis. JAMA 1993; 270: 65–8.

Puljic , Trkanjic Z. , Tekavec J. Tuberculosis—consequences of war. Lancet Conf 1995; No. 1: 11

Buying into the orphan drug market [Editorial]. Lancet 1995; 346: 917

Millard J. Tuberculosis treatment programmes in low-income countries. Lancet 1995; 344: 259–60.